237 related articles for article (PubMed ID: 23878313)
1. Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody.
Oku K; Amengual O; Zigon P; Horita T; Yasuda S; Atsumi T
Rheumatology (Oxford); 2013 Oct; 52(10):1775-84. PubMed ID: 23878313
[TBL] [Abstract][Full Text] [Related]
2. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies.
Vega-Ostertag M; Casper K; Swerlick R; Ferrara D; Harris EN; Pierangeli SS
Arthritis Rheum; 2005 May; 52(5):1545-54. PubMed ID: 15880836
[TBL] [Abstract][Full Text] [Related]
3. The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies.
Bohgaki M; Atsumi T; Yamashita Y; Yasuda S; Sakai Y; Furusaki A; Bohgaki T; Amengual O; Amasaki Y; Koike T
Int Immunol; 2004 Nov; 16(11):1633-41. PubMed ID: 15466912
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway.
López-Pedrera C; Buendía P; Cuadrado MJ; Siendones E; Aguirre MA; Barbarroja N; Montiel-Duarte C; Torres A; Khamashta M; Velasco F
Arthritis Rheum; 2006 Jan; 54(1):301-11. PubMed ID: 16385547
[TBL] [Abstract][Full Text] [Related]
5. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation.
Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T
Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870
[TBL] [Abstract][Full Text] [Related]
6. Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytes.
Fujieda Y; Amengual O; Matsumoto M; Kuroki K; Takahashi H; Kono M; Kurita T; Otomo K; Kato M; Oku K; Bohgaki T; Horita T; Yasuda S; Maenaka K; Hatakeyama S; Nakayama KI; Atsumi T
Rheumatology (Oxford); 2016 Jun; 55(6):1117-26. PubMed ID: 26895716
[TBL] [Abstract][Full Text] [Related]
7. A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells.
Vega-Ostertag M; Liu X; Kwan-Ki H; Chen P; Pierangeli S
Br J Haematol; 2006 Oct; 135(2):214-9. PubMed ID: 16965389
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
Yasuda S; Bohgaki M; Atsumi T; Koike T
Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells.
Chen YJ; Zhang LQ; Wang GP; Zeng H; Lü B; Shen XL; Jiang ZP; Chen FP
Thromb Haemost; 2008 Aug; 100(2):291-300. PubMed ID: 18690350
[TBL] [Abstract][Full Text] [Related]
10. An IgG antiprothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times.
Zhao Y; Rumold R; Zhu M; Zhou D; Ahmed AE; Le DT; Hahn BH; Woods VL; Chen PP
Arthritis Rheum; 1999 Oct; 42(10):2132-8. PubMed ID: 10524684
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of antiphospholipid syndrome-IgG fractions and human monoclonal antiphospholipid IgG antibody on human umbilical vein endothelial cells and monocytes.
Clemens N; Frauenknecht K; Katzav A; Sommer C; von Landenberg P
Ann N Y Acad Sci; 2009 Sep; 1173():805-13. PubMed ID: 19758232
[TBL] [Abstract][Full Text] [Related]
12. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of TF in BMP-7-treated human mononuclear cells depends on activation of select MAPK signaling pathways.
Sovershaev MA; Egorina EM; Sovershaev TA; Svensson B; Hansen JB
Thromb Res; 2011 Dec; 128(6):e154-9. PubMed ID: 21820697
[TBL] [Abstract][Full Text] [Related]
14. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T
Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome.
Cuadrado MJ; Buendía P; Velasco F; Aguirre MA; Barbarroja N; Torres LA; Khamashta M; López-Pedrera C
J Thromb Haemost; 2006 Nov; 4(11):2461-9. PubMed ID: 16968331
[TBL] [Abstract][Full Text] [Related]
16. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome.
Amengual O; Atsumi T; Khamashta MA; Hughes GR
Thromb Haemost; 1998 Feb; 79(2):276-81. PubMed ID: 9493575
[TBL] [Abstract][Full Text] [Related]
17. Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Tonello M; Bontadi A; Salvan E; Banzato A; Pengo V; Punzi L
Lupus; 2012 Jun; 21(7):787-9. PubMed ID: 22635234
[TBL] [Abstract][Full Text] [Related]
18. Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome.
Zhou H
Acta Pharmacol Sin; 2004 Oct; 25(10):1366-71. PubMed ID: 15456541
[TBL] [Abstract][Full Text] [Related]
19. Laminar shear, but not orbital shear, has a synergistic effect with thrombin stimulation on tissue factor expression in human umbilical vein endothelial cells.
Rochier A; Nixon A; Yamashita N; Abe R; Abe R; Madri JA; Sumpio BE
J Vasc Surg; 2011 Aug; 54(2):480-8. PubMed ID: 21367569
[TBL] [Abstract][Full Text] [Related]
20. Chitosan oligosaccharides inhibit the expression of interleukin-6 in lipopolysaccharide-induced human umbilical vein endothelial cells through p38 and ERK1/2 protein kinases.
Liu HT; Li WM; Li XY; Xu QS; Liu QS; Bai XF; Yu C; Du YG
Basic Clin Pharmacol Toxicol; 2010 May; 106(5):362-71. PubMed ID: 19929981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
